KNAX was redesigned in 2020 to develop the first-in-class diagnostic methods to address unmet medical needs. We are expanding range of patient indications from cancer to infectious diseases and striving practical strategies for improving diagnosis and patient outcomes. Besides research and development, KNAX offers products and CDMO/CRO services through diverse affiliates.
Business
#303, World Trade Tower, 511, Yeongdong-daero, Gangnam-gu, Seoul
R&D
#D-1414, Technovally U1 center, 947, Hanam-daero, Hanam-si, Gyeonggi-do
Manufacture
61, Oriental Medicine Expo-ro, Jecheon-si, Chungbuk
IP holdings
KNAX Singapore PTE LTD in Singapore
BGX Life Science
(wholly owned subsidiary)
61, Oriental Medicine Expo-ro, Jecheon-si, Chungbuk
Management and key personals
Tae Hyun Yun
CEO
.CEO at BGX Life Science
.Former CFO at Kookmin Lease
Dr. Yu Jin Shin Ph.D.
Director of R&D
.Former Max Planck scientist
.Biomarker discovery expert
.Cancer researcher at AMC
.Humboldt Univ (Berlin)
Dr. Fred Chung Ph.D.
Scientific Advisor (Singapore)
.CSO at Xylonix.io
.Immunotherapeutic expert
.IP generation expert
.BT strategy expert
Prof. Tae Jung Park
Scientific Advisor (South Korea)
Prof. Mi-Kyung Lee
Scientific Advisor (South Korea)
Prof. Young-Pil Kim
Scientific Advisor (South Korea)
.Professor at Chung-Ang University (Dept. of
Chemistry)
.Director of the Research Institute of Chem-Bio
Diagnostic Technology
.Director of the Integrative Research Center for
Monitoring of Harmful Materials in Chung-Ang
University
.Ph.D., in Chemical & Biomolecular Engineering, KAIST
.Professor at Chung-Ang University (Dept. of
College of Medicine)
.Chief of the Department of Laboratory Medicine
of Chung-Ang University Hospital
.Experience in evaluating various diagnostic reagents
and test kits
.Professor at Hanyang University (Dept. of Life
Science)
.General Secretary, The Korean BioChip Society,
Korea
.Ph.D., in Biological Sciences (nano-bio), KAIST
History
Business
TEL : +82-2-551-7700
FAX : +82-2-551-7701
business@knax.co.kr
R&D
TEL : +82-31-5180-3184
FAX : +82-31-5180-3185
rnd@knax.co.kr
IP holdings
BGX Life Science
(wholly owned subsidiary):